Rosenberg / Gershon | Pharmacotherapy of Child and Adolescent Psychiatric Disorders | E-Book | sack.de
E-Book

E-Book, Englisch, 480 Seiten, E-Book

Rosenberg / Gershon Pharmacotherapy of Child and Adolescent Psychiatric Disorders


3. Auflage 2012
ISBN: 978-1-119-95832-1
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 480 Seiten, E-Book

ISBN: 978-1-119-95832-1
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)



This book fulfils an urgent need for an updated text on pediatricpsychopharmacology. It takes a unique approach in discussing recentfindings within the context of current issues, including economicand political ones. The book covers the emerging question oftreating children who do not yet meet diagnostic criteria forpsychosis, e.g, schizophrenia or bipolar disorder, but who aredeemed to be at high risk. This is an active area of debate: suchchildren are being treated in certain centers, while others rejectthis completely. The book addresses the antidepressant controversy,the placebo response and unique strategies for delineating this,and ways to optimize the differential between active medication andplacebo. It reviews the impact of recent American Heart Associationguidelines for monitoring children on stimulants and otherpsychotropics. It adheres closely to DSM-IV diagnostic criteriathroughout. The book describes the use of newly approved drugs suchas Lexapro for treating adolescent depression and the novelcompound Intuniv. It covers the TADS and CAMS studies, whichevaluated the use of SSRIs alone and in combination with cognitivebehavioral therapy for adolescent depression. Other topics includetreatment of bipolar disorders, the increasing popularity ofgeneric equivalents, combination pharmacotherapy and the potentialdangers of psychotropic medications.
* Third edition of the first ever book published on pediatricpsychopharmacology from renowned editors.
* Incorporates current developments with regard to SSRIs, theirindications and their safety issues, including possible associatedsuicidal behavior.
* Addresses concerns about cardiovascular side effects of the newstimulant medications available, and compares to other FDA-approvedmedications for ADHD.
* Features many tables, figures and pictorials, making it highlyaccessible and reader friendly.

Rosenberg / Gershon Pharmacotherapy of Child and Adolescent Psychiatric Disorders jetzt bestellen!

Weitere Infos & Material


David Rosenberg MD, Miriam L. Hamburger Endowed Chair ofChild Psychiatry and Professor & Chief of Child Psychiatry andPsychology at Wayne State University and the Children's Hospital ofMichigan, Detroit, MI , USA
Samuel Gershon MD, Emeritus Professor of Psychiatry,University of Pittsburgh, PA, USA



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.